Ieq Capital LLC Makes New $447,000 Investment in Rafael Holdings, Inc. $RFL

Key Points

• Ieq Capital LLC has acquired a new stake in Rafael Holdings, purchasing 238,878 shares valued at approximately $447,000, representing about 0.96% of the company.
• Rafael Holdings reported a loss of $0.19 per share for the last quarter, along with a revenue of $0.36 million and a negative net margin of 3,127.60%.
• Wall Street analyst ratings for Rafael were upgraded from a "sell" to a "hold" as of August 10th, reflecting a more positive outlook on the stock.

Ieq Capital LLC purchased a new position in shares of Rafael Holdings, Inc. (NYSE:RFL - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 238,878 shares of the company's stock, valued at approximately $447,000. Ieq Capital LLC owned approximately 0.96% of Rafael at the end of the most recent reporting period.

Separately, Wealth Enhancement Advisory Services LLC acquired a new stake in Rafael during the 1st quarter worth $26,000. Institutional investors own 11.30% of the company's stock.

Rafael Trading Down 6.6%

NYSE:RFL traded down $0.10 during midday trading on Wednesday, hitting $1.35. 120,757 shares of the company were exchanged, compared to its average volume of 98,243. The company has a fifty day simple moving average of $1.75 and a 200 day simple moving average of $1.73. Rafael Holdings, Inc. has a fifty-two week low of $1.28 and a fifty-two week high of $3.19. The company has a market capitalization of $47.20 million, a PE ratio of -1.43 and a beta of 0.89.

Rafael (NYSE:RFL - Get Free Report) last issued its quarterly earnings data on Wednesday, June 11th. The company reported ($0.19) earnings per share (EPS) for the quarter. Rafael had a negative return on equity of 24.75% and a negative net margin of 3,127.60%.The business had revenue of $0.36 million for the quarter.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen lowered shares of Rafael from a "hold" rating to a "sell" rating in a research note on Friday, September 5th.

Rafael Company Profile

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.